Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 21, 2008Antimicrobial Agents and ChemotherapyOpen Access

Selection and Characterization of Hepatitis C Virus Replicons Dually Resistant to the Polymerase and Protease Inhibitors HCV-796 and Boceprevir (SCH 503034)

View Full Paper
Ask AI
Bookmark
Share

Authors

MFMike FlintCenters for Disease Control and PreventionSMStanley MullenADAnne M. DeatlyPfizer (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Flint et al. (2008) studied this question.

synapsesocial.com/papers/6a908d06e8d327d500343bc5https://doi.org/10.1128/aac.01081-08
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Hepatitis C Virus Replicon Presents a Higher Barrier to Resistance to Nucleoside Analogs than to Nonnucleoside Polymerase or Protease Inhibitors2008 · 164 citations
  2. 2Recent Advances in Discovery and Development of Promising Therapeutics against Hepatitis C Virus NS5B RNA-Dependent RNA Polymerase2005 · 26 citations
  3. 3Allosteric Inhibition of the Hepatitis C Virus NS5B RNA Dependent RNA Polymerase2006 · 52 citations
  4. 4Consensus Proposals for a Unified System of Nomenclature of Hepatitis C Virus Genotypes *2005 · 1,517 citations
  5. 5Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy1998 · 2,129 citations